Piramal Pharma Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Piramal Pharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 6719 Piramal Pharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Piramal Pharma has purchased the following applications: IBM Cloud (formerly IBM Bluemix and IBM SoftLayer) for Application Hosting and Computing Services in 2017, Microsoft Azure Monitor for Application Performance Management in 2024, SAP S/4 HANA for ERP Financial in 2025 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Piramal Pharma is running and its propensity to invest more and deepen its relationship with IBM , Data Foundry , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Piramal Pharma revenues, which have grown to $1.06 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Piramal Pharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.